📋 Tender Overview
Contract awarded for Framework agreement for oncological medicines 16 batches lot-0005, title: paclitaxel conc. pt. sol. perf. 6mg/ml - 25 ml, description: paclitaxel conc. pt. sol. perf. 6mg/ml - 25 ml minimum quantity framework agreement 30 maximum quantity framework agreement 350 lot-0006, title: docetaxel conc. pt. sol. / perf. 20mg/ml - 4ml, description: docetaxel conc. pt. sol. / perf. 20mg/ml - 4ml minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0010, title: oxaliplatin liof. pt. sol. / perf. 5mg/ml - 20 ml / 100 mg, description: oxaliplatin liof. pt. sol. / perf. 5mg/ml - 20 ml / 100 mg minimum quantity framework agreement 10 maximum quantity framework agreement 500 lot-0012, title: carboplatin conc. pt. sol. / perf. 10mg/ml - 15ml, description: carboplatin conc. pt. sol. / perf. 10mg/ml - 15ml minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0015, title: etoposide conc. pt. sol. / perf. 20 mg/ml-10 ml, description: etoposide conc. pt. sol. / perf. 20 mg/ml-10 ml minimum quantity framework agreement 10 maximum quantity framework agreement 200 lot-0016, title: pemetrexed pulb. pt. sol. perf. 25mg/ml-20 ml 500 mg, description: pemetrexed pulb. pt. sol. perf. 25mg/ml-20 ml 500 mg minimum quantity framework agreement 10 maximum quantity framework agreement 200 estimated value excluding vat: 24666.00 ron.Framework agreement for oncological medicines 16 batches